DPC423 is a selective and orally active factor Xa inhibitor with a K i s of 0.15 (human) and 0.3 (rabbit) nM. DPC423 exhibits K i s of 60, 61 and 6000 nM against human trypsin , plasma kallikrein and thrombin . DPC423 blocks the formation of prothrombinase complex, reduces thrombin production, inhibits fibrin formation and platelet activation. DPC423 can be used for the study of anticoagulation of arterial thrombosis.
Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Factor Xa | Products > Signaling Pathways > Kallikrein | Products > Signaling Pathways > Thrombin | Products > Signaling Pathways > Ser/Thr Protease
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.